SCHEMBL19246906

SCHEMBL19246906

c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5cc6c7ccccc7n(-c7ccccc7)c6cc54)cc3)nc3c2sc2ccccc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 3/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ TNKS O95271 2/20 0.33
▸ TNKS2 Q9H2K2 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ PTGER4 P35408 1/20 0.31
▸ PIK3CA P42336 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ GAA P10253 1/20 0.30
▸ NPY5R Q15761 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ HTR1A P08908 2/20 0.30
▸ HTR7 P34969 2/20 0.30
▸ PDE1B Q01064 1/20 0.30
▸ PDE3A Q14432 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19247821 1.00 ATM (0.38) ATMKDM4EL3MBTL1TNKSTNKS2
SCHEMBL19247902 0.97 ATM (0.38) ATMKDM4EL3MBTL1TNKSTNKS2
SCHEMBL19246968 0.97 ATM (0.38) ATMKDM4EL3MBTL1TNKSTNKS2
SCHEMBL16581191 0.94 ATM (0.38) ATMKDM4EL3MBTL1TNKSTNKS2
SCHEMBL16905927 0.94 ATM (0.40) ATMKDM4EL3MBTL1TNKSTNKS2
SCHEMBL19246907 0.93 ATM (0.33) ATMKDM4EL3MBTL1TNKSTNKS2
SCHEMBL19247822 0.93 ATM (0.33) ATMKDM4EL3MBTL1TNKSTNKS2
SCHEMBL24283017 0.93 ATM (0.37) ATMKDM4EL3MBTL1MEN1KMT2A
SCHEMBL19247824 0.93 ATM (0.37) ATMKDM4EL3MBTL1TNKSTNKS2
SCHEMBL19246911 0.93 L3MBTL1 (0.37) ATMKDM4EL3MBTL1TNKSTNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-22 — — US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 — — US disclosed
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170237015-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNA1, ARL1 ATM 638/4885KDM4E 4143/4885L3MBTL1 470/4885
US-10873034-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNA1, ARL1 ATM 638/4885KDM4E 4143/4885L3MBTL1 470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback